Roles and signaling pathways of CITED1 in tumors: overview and novel insights
Wenting Chen1,2, Jianing Jiang1,2, Jinqi Gao3
1Department of Oncology Medicine, Affiliated Zhongshan Hospital of Dalian University, Dalian, China.
Abstract:
CBP/p300 interacting transactivator with Glu/Asp-rich carboxy-terminal domain 1 (CITED1) is a transcriptional activator belonging to the non-DNA-binding transcription co-regulator family. It regulates diverse pathways, including the transforming growth factor/bone morphogenetic protein/SMAD, estrogen, Wnt-β-catenin, and androgen-AR signaling pathways, by binding to CBP/p300 co-activators through its conserved transactivation domain CR2. CITED1 plays an important role in embryonic development and a certain regulatory role in the occurrence and development of various tumors. In this article, the biological characteristics, expression regulation, participating signaling pathways, and potential roles of CITED1 in the clinical diagnosis and treatment of tumors are reviewed.
Insights
CBP/p300 interacting transactivator with Glu/Asp-rich carboxy-terminal domain 1 (CITED1) is a transcriptional co-regulator involved in embryonic development and tumor progression. This review covers CITED1's biological roles, signaling pathways, and potential in cancer diagnosis and treatment.
Area of Science:
- Molecular Biology
- Cancer Research
- Gene Regulation
Background:
- CBP/p300 interacting transactivator with Glu/Asp-rich carboxy-terminal domain 1 (CITED1) is a transcriptional co-regulator.
- It lacks DNA-binding capacity but interacts with CBP/p300 co-activators via its CR2 domain.
Purpose of the Study:
- To review the biological characteristics of CITED1.
- To examine its role in regulating diverse signaling pathways.
- To explore its potential in tumor diagnosis and treatment.
Main Methods:
- Literature review of CITED1's functions.
- Analysis of its involvement in key signaling pathways (TGF-β/BMP/SMAD, Estrogen, Wnt-β-catenin, Androgen-AR).
- Evaluation of its role in embryonic development and tumorigenesis.
Main Results:
- CITED1 regulates multiple signaling pathways crucial for development and cancer.
- It plays a significant role in the occurrence and progression of various tumors.
- Its biological characteristics and expression regulation are critical for its function.
Conclusions:
- CITED1 is a key transcriptional co-regulator with implications in embryonic development.
- Its dysregulation is linked to various cancers, suggesting potential as a diagnostic and therapeutic target.
- Further research into CITED1's pathways can advance cancer treatment strategies.
More Related Videos
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
09:08Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Non-Canonical Wnt Signaling Pathways
Canonical Wnt Signaling Pathway
Hedgehog Signaling Pathway
